Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Addressing growing healthcare demands with computer assisted medicine

  • In News
  • June 29, 2021
  • Samantha Freidin
Addressing growing healthcare demands with computer assisted medicine

With more pressure than ever on the healthcare system, scalability is everything. How can we expand the system to meet increased demands by users?

Pacific Knowledge Systems (ASX: PKS) is addressing this complex issue through their technology stack by providing software applications to better capture, apply and manage human expertise to enhance business performance and improve patient outcomes.

The Company has today announced the successful renewal of key contracts, boasting a near complete contract renewal rate of 99% which exceeds expectations for recurrent revenue.

Major clients who have renewed their contracts with PKS include Healthscope, St Vincent’s Private, Uniting Care, St John of God, and Cabrini. State government health departments in NSW, Victoria, South Australia, Northern Territory and Tasmania have also renewed their contracts.

St Vincent’s Health Australia renewed license agreements for PKS products based on a reported reduction in the number of hospital acquired complications across the private health network by an average of 16% between FY 2019-2020.

Victorian public health authorities recently integrated PKS’ RISQ software as part of a state-wide agreement to improve safety and quality of large-scale healthcare operations. The RISQ platform reviews patient records in datasets to evaluate quality of data and incidences of hospital acquired complications. This effectively benchmarks hospitals against statistical peers to provide industry benchmarks and foster clinical excellence and continuous quality improvement.

PKS’ flagship decision support platform RippleDown has been retained by Australian Clinical Labs, the Asian Pacific Healthcare Group and Lancet (South Africa) with all organisations resigning licensing agreements. RippleDown has also been renewed for use by Phillips in The Netherlands which will see the expansion of the platform for use in microbiology, opening up further revenue opportunities. The tech is able to aggregate data from experts and various data sources to generate insightful information to support clinical decision making. This improves the decision making process by removing subjectivity and improves operational workflow. The program allows expert decision making at scale to allow more decisions to be made at a rapid pace, with increased accuracy.

PKS has also won several new contracts including Ramsay hospitals and across the Mater Group in Queensland. The Ministry of Health in Singapore is set to commence a trial of the RISQ and PICQ software with a view to rolling the programs out in all public and private hospitals in Singapore. The PICQ software is designed to assess data quality within patient records and identify records for correction.

PKS’s programs have the ability to address many challenges of healthcare delivery at scale. Following the recent acquisition of Pavillion Health, PKS now has four proprietary software offerings all designed to improve patient outcomes and streamline decision making processes.

The Company remains focused on the future with product development high on the list of priorities, creating products that have impressive data integration capabilities and agility to adapt to the rapidly changing healthcare landscape.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • australian clinical labs
  • healthcare
  • medtech
  • pacific knowledge systems
  • picq
  • pks
  • risq
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.